Ceryvyn Therapeutics Limited(CYVNY)
$0.03+0.01 (+86.67%)
CYVNY
Ceryvyn Therapeutics Limited financials statements
$0.03
At close:+0.01 (+86.67%)
Want to see CYVNY full AI Analyst Report?
Ceryvyn Therapeutics Limited (CYVNY) Income Statement
190 Followers
Ceryvyn Therapeutics Limited Income Statement
Last quarter (Q4 2024), Ceryvyn Therapeutics Limited's total revenue was AU$89.39K, an increase of 35.24% from the same quarter last year. In Q4, Ceryvyn Therapeutics Limited's net income was AU$-185.99M. See Ceryvyn Therapeutics Limited’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 24 | Jun 23 | Jun 22 | Jun 21 | Jun 20 |
|---|---|---|---|---|---|
| AU$ 124.67K | AU$ 161.16K | AU$ 125.05K | AU$ 91.98K | AU$ 145.90K | |
| AU$ 21.72K | AU$ -89.31K | AU$ -107.42K | AU$ -480.00K | AU$ -371.37K | |
| AU$ 191.97M | AU$ 223.46M | AU$ 133.29M | AU$ 53.13M | AU$ 24.71M | |
| Depreciation and Amortization | AU$ 103.03K | AU$ 150.49K | AU$ 108.08K | AU$ 143.00K | AU$ 144.02K |
| AU$ -200.02M | AU$ -223.30M | AU$ -99.01M | AU$ -50.14M | AU$ -24.92M | |
| AU$ -191.84M | AU$ -223.45M | AU$ -133.27M | AU$ -53.18M | AU$ -24.70M | |
| AU$ -37.81M | AU$ -70.67M | AU$ -3.41M | AU$ -14.23M | AU$ 310.76K | |
| AU$ -229.65M | AU$ -220.69M | AU$ -136.68M | AU$ -67.41M | AU$ -24.39M | |
| AU$ -220.24M | AU$ -211.88M | AU$ -127.99M | AU$ -60.79M | AU$ -16.12M | |
| Per Share Metrics | |||||
| Basic EPS | AU$ -22.16 | AU$ -3.60 | AU$ -2.72 | AU$ -1.44 | AU$ -0.50 |
| Diluted EPS | AU$ -22.16 | AU$ -3.60 | AU$ -2.72 | AU$ -1.44 | AU$ -0.49 |
| Weighted Average Shares Outstanding | 79.78M | 58.69M | 46.62M | 42.49M | 32.56M |
| Weighted Average Shares Outstanding (Diluted) | 79.78M | 58.69M | 46.62M | 42.49M | 32.60M |
Currency in AUD

